4//SEC Filing
Biostage, Inc. 4
Accession 0001144204-17-015099
$HRGNCIK 0001563665operating
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:19 PM ET
Size
8.0 KB
Accession
0001144204-17-015099
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
McNaughton Thomas
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2017-03-14+74,250→ 74,250 total→ Common Stock, par value $0.01 per share (74,250 underlying) - Award
Stock Option (right to buy)
2017-03-14+150,750→ 150,750 totalExercise: $0.38Exp: 2027-03-14→ Common Stock, par value $0.01 per share (150,750 underlying)
Footnotes (3)
- [F1]The option shares vest in four equal installments on March 14, 2018, 2019, 2020 and 2021.
- [F2]Restricted stock units granted by the Issuer pursuant to its 2013 Equity Incentive Plan and qualified under Rule 16b-3(d). Each restricted stock unit represents a contingent right to receive one share of Common Stock of the Issuer.
- [F3]The restricted stock units vest and settle in four equal installments on March 14, 2018, 2019, 2020 and 2021.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001563665
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:19 PM ET
- Size
- 8.0 KB